WC
Wexford Capital Portfolio holdings
AUM
$359M
1-Year Return
31.38%
This Quarter Return
+20.07%
1 Year Return
+31.38%
3 Year Return
+167.75%
5 Year Return
–
10 Year Return
–
AUM
$359M
AUM Growth
-$26M
(-6.8%)
Cap. Flow
-$59.4M
Cap. Flow
% of AUM
-16.57%
Top 10 Holdings %
Top 10 Hldgs %
47.08%
Holding
344
New
127
Increased
37
Reduced
53
Closed
104
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.3M |
| 2 |
Comcast
CMCSA
|
+$7.49M |
| 3 |
Amazon
AMZN
|
+$7.2M |
| 4 |
Century Aluminum
CENX
|
+$5.55M |
| 5 |
Cleveland-Cliffs
CLF
|
+$5.16M |
Top Sells
| 1 |
X
US Steel
X
|
+$29M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$10.9M |
| 3 |
Sempra
SRE
|
+$8.5M |
| 4 |
Invesco China Technology ETF
CQQQ
|
+$7.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$5.59M |
Sector Composition
| 1 | Industrials | 22.41% |
| 2 | Materials | 16.93% |
| 3 | Energy | 14.24% |
| 4 | Healthcare | 9.43% |
| 5 | Utilities | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Broadcom
AVGO
$1.7T
| $175K | 0.05% |
636
-620
| -49% | -$171K |
|
177
Rezolute
RZLT
$669M
| $171K | 0.05% |
+38,348
| New | +$171K |
|
178
MasTec
MTZ
$15B
| $170K | 0.05% |
+1,000
| New | +$170K |
|
179
Cytokinetics
CYTK
$6.12B
| $169K | 0.05% |
+5,107
| New | +$169K |
|
180
Arcutis Biotherapeutics
ARQT
$2.07B
| $162K | 0.05% |
+11,558
| New | +$162K |
|
181
Vera Therapeutics
VERA
$1.52B
| $162K | 0.05% |
6,864
-35,441
| -84% | -$835K |
|
182
Applied Industrial Technologies
AIT
$9.94B
| $161K | 0.05% |
694
-454
| -40% | -$106K |
|
|
MTSR
183
Metsera, Inc. Common Stock
MTSR
$3.75B
| $160K | 0.04% |
+5,633
| New | +$160K |
|
184
Ouster
OUST
$1.67B
| $160K | 0.04% |
+6,582
| New | +$160K |
|
185
Arcellx
ACLX
$4.23B
| $159K | 0.04% |
2,420
-10,387
| -81% | -$684K |
|
186
Golar LNG
GLNG
$4.16B
| $159K | 0.04% |
3,863
| – | – |
|
187
Nuvation Bio
NUVB
$1.07B
| $159K | 0.04% |
81,590
-691,329
| -89% | -$1.35M |
|
188
Apellis Pharmaceuticals
APLS
$3.14B
| $158K | 0.04% |
+9,139
| New | +$158K |
|
|
SLN
189
Silence Therapeutics
SLN
$213M
| $157K | 0.04% |
+27,149
| New | +$157K |
|
|
ACOG
190
Alpha Cognition Inc. Common Stock
ACOG
$158M
| $155K | 0.04% |
+16,666
| New | +$155K |
|
191
Janux Therapeutics
JANX
$1.45B
| $151K | 0.04% |
+6,541
| New | +$151K |
|
192
Arrowhead Research
ARWR
$4.11B
| $146K | 0.04% |
+9,229
| New | +$146K |
|
193
STMicroelectronics
STM
$23.1B
| $144K | 0.04% |
+4,724
| New | +$144K |
|
194
Cullinan Oncology
CGEM
$386M
| $141K | 0.04% |
+18,726
| New | +$141K |
|
195
Timken Company
TKR
$5.4B
| $140K | 0.04% |
+1,925
| New | +$140K |
|
196
Allegro MicroSystems
ALGM
$5.51B
| $139K | 0.04% |
+4,070
| New | +$139K |
|
197
ON Semiconductor
ON
$19.7B
| $135K | 0.04% |
+2,570
| New | +$135K |
|
198
Regal Rexnord
RRX
$9.22B
| $132K | 0.04% |
+912
| New | +$132K |
|
199
Curtiss-Wright
CW
$19.2B
| $127K | 0.04% |
+260
| New | +$127K |
|
200
Coca-Cola Femsa
KOF
$18B
| $126K | 0.04% |
1,298
-57,214
| -98% | -$5.53M |
|